Clinical Trials in Philadelphia

Showing 4401-4420 of 20,904 trials

TERMINATEDPhase 1< 1 mile

Tasquinimod for the Treatment of Relapsed or Refractory Myeloma

NCT04405167

This study is the first study of tasquinimod, an inhibitor of S100A9, in patients with multiple myeloma.

Multiple Myeloma

University of Pennsylvania30 participantsStarted Jul 2020

Philadelphia, Pennsylvania, United States

Active Not RecruitingPhase 2< 1 mile

Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD

NCT05612035

Researchers are looking for ways to treat pulmonary hypertension (PH) caused by chronic obstructive pulmonary disease (COPD). The goal of the study is to learn if people who take frespaciguat can walk farther in 6 minutes at Week 24 compared to people who take placebo.

Pulmonary HypertensionChronic Obstructive Pulmonary Disease

Merck Sharp & Dohme LLC120 participantsStarted Mar 2023

San Francisco, California, United States • Aurora, Colorado, United States • Sebring, Florida, United States +81 more locations

Tasquinimod for the Treatment of Relapsed or Refractory Myeloma

Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD

Find Trials by Condition in Philadelphia

Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory or Relapsed Follicular Lymphoma

Parkinson's Disease and Movement Disorders Clinical Database

Imaging Retinal Vasculature in Infant Eyes

Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant

African Cancer Genome: GMD

P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion With Instrumentation

Criterion-learning Naming Treatment For Addressing Comprehension Deficits in Aphasia

EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction

PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer

Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer

Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)

Cognitive Remediation for Coordinated Specialty Care

Acquired Dyslexia Modeling and Treatment

Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Kaneka Endovascular Embolization and Protection

Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

CBX-12 for the Treatment of Metastatic Chemotherapy-Refractory Microsatellite Stable Colorectal Cancer

A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis